Bio Protocol’s AUBRAI Generates $180,000 in Fees and $20 Million in Trading Volume

Paul Kohlhaas reports AUBRAI’s early success, with plans to launch new tools like the aubr.ai terminal and introduce innovative research funding mechanisms.

IP

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.